-+ 0.00%
-+ 0.00%
-+ 0.00%

Asian Market Insights: 3 Stocks Like Shenzhen Kinwong Electronic That May Be Underestimated

Simply Wall St·07/10/2026 04:07:45
Listen to the news

As global markets navigate mixed signals, with Japan experiencing a divergence in stock performance and China's manufacturing showing resilience, investors are increasingly looking toward Asia for opportunities that may be underestimated. In such an environment, identifying undervalued stocks involves assessing companies with strong fundamentals that might not yet be fully appreciated by the market, offering potential for growth as conditions evolve.

Top 10 Undervalued Stocks Based On Cash Flows In Asia

Name Current Price Fair Value (Est) Discount (Est)
Zhongji Innolight (SZSE:300308) CN¥1194.90 CN¥2338.95 48.9%
Shenzhen Yanmade Technology (SHSE:688312) CN¥66.20 CN¥132.37 50%
Rakus (TSE:3923) ¥1029.00 ¥2011.31 48.8%
NC Chem (KOSDAQ:A482630) ₩13040.00 ₩25754.36 49.4%
Matrix Design (SZSE:301365) CN¥36.86 CN¥72.78 49.4%
Laopu Gold (SEHK:6181) HK$383.00 HK$746.24 48.7%
Kunshan Dongwei TechnologyLtd (SHSE:688700) CN¥76.11 CN¥148.50 48.7%
Contec.Co.Ltd (KOSDAQ:A451760) ₩8100.00 ₩16175.23 49.9%
APT Medical (SHSE:688617) CN¥197.35 CN¥388.60 49.2%
Addvalue Technologies (SGX:A31) SGD0.133 SGD0.26 48.9%

Click here to see the full list of 182 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.

Let's explore several standout options from the results in the screener.

Shenzhen Kinwong Electronic (SHSE:603228)

Overview: Shenzhen Kinwong Electronic Co., Ltd. is involved in the research, development, production, and sale of printed circuit boards and electronic materials both in China and internationally, with a market cap of CN¥67.32 billion.

Operations: The company's revenue primarily comes from its Printed Circuit Board segment, which generated CN¥15.86 billion.

Estimated Discount To Fair Value: 45.8%

Shenzhen Kinwong Electronic is trading at CN¥68.25, significantly below its estimated cash flow value of CN¥125.91, indicating it may be undervalued based on cash flows. Despite recent volatility in its share price and a dividend not well covered by free cash flows, the company's earnings are forecast to grow 48.1% annually over the next three years, outpacing both industry peers and the broader Chinese market's growth expectations.

SHSE:603228 Discounted Cash Flow as at Jul 2026
SHSE:603228 Discounted Cash Flow as at Jul 2026

APT Medical (SHSE:688617)

Overview: APT Medical Inc. focuses on the research, development, production, and sale of cardiovascular interventional medical devices in China with a market cap of CN¥27.85 billion.

Operations: The company generates revenue from its medical products segment, which amounted to CN¥2.72 billion.

Estimated Discount To Fair Value: 49.2%

APT Medical is trading at CN¥197.35, significantly below its estimated cash flow value of CN¥388.6, highlighting potential undervaluation based on cash flows. The company recently completed a share buyback program worth CNY 99.98 million, enhancing shareholder value. Despite an unstable dividend history and earnings growth forecasted to be slower than the Chinese market average, APT Medical's revenue is expected to grow faster than the market at 22.3% annually.

SHSE:688617 Discounted Cash Flow as at Jul 2026
SHSE:688617 Discounted Cash Flow as at Jul 2026

MonotaRO (TSE:3064)

Overview: MonotaRO Co., Ltd. operates an online store specializing in maintenance, repair, and operations (MRO) products for factories both in Japan and internationally, with a market capitalization of approximately ¥971.12 billion.

Operations: The company generates revenue primarily through its Indirect Material Sales Business for Factories, amounting to ¥350.36 billion.

Estimated Discount To Fair Value: 24.3%

MonotaRO is trading at ¥1,975, below its estimated future cash flow value of ¥2,608.95, suggesting potential undervaluation. The company reported strong sales growth in recent months and completed a share buyback totaling ¥9.99 billion. However, its dividend yield of 1.87% is not well covered by free cash flows. Earnings are projected to grow at 12% annually, outpacing the Japanese market average while maintaining a high forecasted return on equity of 28.4%.

TSE:3064 Discounted Cash Flow as at Jul 2026
TSE:3064 Discounted Cash Flow as at Jul 2026

Turning Ideas Into Actions

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.